Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Megakaryocytes | 20 | 2004 | 24 | 1.410 |
Why?
|
| Blood Platelets | 10 | 2004 | 35 | 0.820 |
Why?
|
| Bone Marrow Cells | 8 | 2005 | 51 | 0.390 |
Why?
|
| Animals | 29 | 2009 | 3289 | 0.350 |
Why?
|
| Osteogenesis | 3 | 2009 | 99 | 0.350 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2009 | 43 | 0.310 |
Why?
|
| Ultrasonic Therapy | 1 | 2009 | 21 | 0.300 |
Why?
|
| Guinea Pigs | 15 | 2004 | 23 | 0.290 |
Why?
|
| Stromal Cells | 2 | 2005 | 31 | 0.270 |
Why?
|
| Cell Culture Techniques | 2 | 2004 | 31 | 0.260 |
Why?
|
| Cell Differentiation | 5 | 2004 | 123 | 0.250 |
Why?
|
| Rats | 10 | 2009 | 619 | 0.250 |
Why?
|
| Cells, Cultured | 12 | 2005 | 460 | 0.230 |
Why?
|
| Titanium | 2 | 2005 | 139 | 0.210 |
Why?
|
| Thrombopoietin | 3 | 1997 | 3 | 0.210 |
Why?
|
| Interleukin-6 | 2 | 1997 | 70 | 0.210 |
Why?
|
| Immunomagnetic Separation | 1 | 2004 | 2 | 0.200 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 108 | 0.200 |
Why?
|
| Recombinant Proteins | 7 | 2009 | 162 | 0.170 |
Why?
|
| Cytoskeleton | 5 | 1990 | 33 | 0.170 |
Why?
|
| Thrombocytopenia | 3 | 1991 | 21 | 0.150 |
Why?
|
| Bone Regeneration | 3 | 2005 | 68 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 3 | 2005 | 81 | 0.150 |
Why?
|
| Nerve Regeneration | 2 | 2009 | 13 | 0.140 |
Why?
|
| Integrins | 2 | 1995 | 9 | 0.140 |
Why?
|
| Blood Proteins | 2 | 1997 | 17 | 0.140 |
Why?
|
| Stem Cells | 2 | 1995 | 34 | 0.130 |
Why?
|
| Receptors, Cytoadhesin | 2 | 1995 | 2 | 0.120 |
Why?
|
| Microtubules | 4 | 1990 | 26 | 0.110 |
Why?
|
| Extracellular Matrix | 2 | 1992 | 47 | 0.110 |
Why?
|
| Ultrasonics | 2 | 2005 | 10 | 0.110 |
Why?
|
| Adenosine Diphosphate | 3 | 1986 | 4 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2008 | 309 | 0.110 |
Why?
|
| Male | 11 | 2009 | 12609 | 0.110 |
Why?
|
| Glycoproteins | 3 | 1992 | 41 | 0.100 |
Why?
|
| Ploidies | 2 | 1991 | 8 | 0.100 |
Why?
|
| Models, Animal | 3 | 2009 | 100 | 0.100 |
Why?
|
| Bone Density | 2 | 2009 | 145 | 0.080 |
Why?
|
| Microbial Collagenase | 1 | 1990 | 12 | 0.080 |
Why?
|
| Fibrinogen | 2 | 1992 | 22 | 0.080 |
Why?
|
| Rats, Inbred WF | 2 | 1991 | 6 | 0.080 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 25 | 0.080 |
Why?
|
| Rats, Long-Evans | 1 | 2009 | 10 | 0.080 |
Why?
|
| Sodium | 3 | 1986 | 56 | 0.070 |
Why?
|
| Ossification, Heterotopic | 1 | 2009 | 32 | 0.070 |
Why?
|
| Guided Tissue Regeneration | 1 | 2009 | 8 | 0.070 |
Why?
|
| X-Ray Microtomography | 1 | 2009 | 74 | 0.070 |
Why?
|
| Axons | 1 | 2009 | 24 | 0.070 |
Why?
|
| G(M1) Ganglioside | 1 | 2008 | 2 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 314 | 0.070 |
Why?
|
| Rodent Diseases | 1 | 1988 | 1 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 69 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 294 | 0.070 |
Why?
|
| Radiculopathy | 1 | 2008 | 41 | 0.070 |
Why?
|
| Thrombin | 3 | 1993 | 14 | 0.070 |
Why?
|
| Actinin | 2 | 1984 | 7 | 0.060 |
Why?
|
| Cell Division | 2 | 1997 | 79 | 0.060 |
Why?
|
| Mandible | 1 | 2005 | 9 | 0.060 |
Why?
|
| Osteogenesis, Distraction | 1 | 2005 | 8 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1992 | 52 | 0.060 |
Why?
|
| Implants, Experimental | 1 | 2005 | 32 | 0.060 |
Why?
|
| Osteoblasts | 1 | 2005 | 52 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2005 | 64 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 62 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 54 | 0.050 |
Why?
|
| Gene Expression | 1 | 2005 | 175 | 0.050 |
Why?
|
| Surface Properties | 1 | 2004 | 103 | 0.050 |
Why?
|
| Collagen | 4 | 2009 | 79 | 0.050 |
Why?
|
| Receptors, Vitronectin | 2 | 1995 | 5 | 0.050 |
Why?
|
| Alloys | 1 | 2004 | 75 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 1984 | 26 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2004 | 68 | 0.050 |
Why?
|
| Materials Testing | 1 | 2004 | 100 | 0.050 |
Why?
|
| Microscopy, Electron | 3 | 1990 | 59 | 0.050 |
Why?
|
| In Vitro Techniques | 3 | 1990 | 150 | 0.050 |
Why?
|
| Ionophores | 1 | 1983 | 2 | 0.050 |
Why?
|
| Hematopoiesis | 2 | 1997 | 10 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 1982 | 20 | 0.040 |
Why?
|
| Cell Movement | 3 | 1987 | 75 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 164 | 0.040 |
Why?
|
| Bone Development | 1 | 2001 | 29 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2001 | 131 | 0.040 |
Why?
|
| Cell Separation | 2 | 1991 | 21 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1990 | 20 | 0.030 |
Why?
|
| Interleukin-11 | 1 | 1997 | 5 | 0.030 |
Why?
|
| Marine Toxins | 1 | 1997 | 1 | 0.030 |
Why?
|
| Oxazoles | 1 | 1997 | 1 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1997 | 2 | 0.030 |
Why?
|
| Thymidine | 1 | 1997 | 6 | 0.030 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1997 | 6 | 0.030 |
Why?
|
| Okadaic Acid | 1 | 1997 | 5 | 0.030 |
Why?
|
| Genistein | 1 | 1997 | 5 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1997 | 13 | 0.030 |
Why?
|
| Phosphates | 1 | 1997 | 16 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 1997 | 46 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1997 | 9 | 0.030 |
Why?
|
| Phosphorylation | 1 | 1997 | 130 | 0.030 |
Why?
|
| Kinetics | 1 | 1997 | 176 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 114 | 0.030 |
Why?
|
| Actins | 2 | 1990 | 35 | 0.030 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 1995 | 6 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1995 | 30 | 0.030 |
Why?
|
| Antibodies | 1 | 1995 | 43 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1995 | 47 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 1984 | 30 | 0.030 |
Why?
|
| Amiloride | 2 | 1983 | 3 | 0.020 |
Why?
|
| Dogs | 2 | 2005 | 136 | 0.020 |
Why?
|
| Laminin | 2 | 2009 | 5 | 0.020 |
Why?
|
| Drug Combinations | 2 | 2009 | 31 | 0.020 |
Why?
|
| Prothrombin | 1 | 1993 | 4 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 1993 | 17 | 0.020 |
Why?
|
| Vitronectin | 1 | 1992 | 1 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1992 | 21 | 0.020 |
Why?
|
| Culture Media | 1 | 1992 | 28 | 0.020 |
Why?
|
| Blood | 1 | 1992 | 15 | 0.020 |
Why?
|
| Proteoglycans | 2 | 2009 | 118 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 148 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1992 | 59 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 182 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2005 | 578 | 0.020 |
Why?
|
| Membrane Fluidity | 1 | 1991 | 6 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 1991 | 15 | 0.020 |
Why?
|
| Magnetics | 1 | 1991 | 1 | 0.020 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1991 | 6 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2005 | 274 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1991 | 31 | 0.020 |
Why?
|
| Nocodazole | 1 | 1990 | 1 | 0.020 |
Why?
|
| Alkaloids | 1 | 1990 | 3 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 1990 | 4 | 0.020 |
Why?
|
| Paclitaxel | 1 | 1990 | 49 | 0.020 |
Why?
|
| Mice | 2 | 2009 | 1247 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2009 | 7 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2009 | 34 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2009 | 21 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2009 | 24 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 115 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 73 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2008 | 242 | 0.020 |
Why?
|
| Cytochalasins | 1 | 1987 | 1 | 0.020 |
Why?
|
| Vincristine | 1 | 1987 | 23 | 0.020 |
Why?
|
| Colchicine | 1 | 1987 | 10 | 0.020 |
Why?
|
| Cell Survival | 1 | 1987 | 97 | 0.020 |
Why?
|
| Rabbits | 1 | 1987 | 165 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 526 | 0.010 |
Why?
|
| Microradiography | 1 | 2005 | 3 | 0.010 |
Why?
|
| Mandibular Nerve | 1 | 2005 | 4 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 2005 | 17 | 0.010 |
Why?
|
| Hydroxyapatites | 1 | 2005 | 5 | 0.010 |
Why?
|
| Shear Strength | 1 | 2005 | 7 | 0.010 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2005 | 13 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 2005 | 28 | 0.010 |
Why?
|
| Growth Substances | 1 | 2005 | 27 | 0.010 |
Why?
|
| Calcium Phosphates | 1 | 2005 | 16 | 0.010 |
Why?
|
| Genes, jun | 1 | 2005 | 4 | 0.010 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2005 | 5 | 0.010 |
Why?
|
| Osteonectin | 1 | 2005 | 5 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 7 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 5 | 0.010 |
Why?
|
| Osteopontin | 1 | 2005 | 5 | 0.010 |
Why?
|
| Genes, myc | 1 | 2005 | 8 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2005 | 28 | 0.010 |
Why?
|
| Internal Fixators | 1 | 2005 | 33 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 23 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 29 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 2008 | 272 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2005 | 124 | 0.010 |
Why?
|
| Immunoelectrophoresis | 1 | 1985 | 1 | 0.010 |
Why?
|
| Chemical Precipitation | 1 | 1985 | 1 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1985 | 5 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2005 | 32 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 23 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 125 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2005 | 107 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2005 | 149 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 231 | 0.010 |
Why?
|
| Monensin | 1 | 1983 | 1 | 0.010 |
Why?
|
| Nigericin | 1 | 1983 | 1 | 0.010 |
Why?
|
| Cations, Monovalent | 1 | 1983 | 11 | 0.010 |
Why?
|
| Serotonin | 1 | 1983 | 22 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 1983 | 2 | 0.010 |
Why?
|
| Calcimycin | 1 | 1983 | 4 | 0.010 |
Why?
|
| Potassium | 1 | 1983 | 59 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1983 | 126 | 0.010 |
Why?
|
| Femur | 1 | 2005 | 298 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1983 | 167 | 0.010 |
Why?
|
| Filamins | 1 | 1982 | 3 | 0.010 |
Why?
|
| Contractile Proteins | 1 | 1982 | 3 | 0.010 |
Why?
|
| Myosins | 1 | 1982 | 3 | 0.010 |
Why?
|
| Arachidonic Acids | 1 | 1982 | 6 | 0.010 |
Why?
|
| Tubulin | 1 | 1982 | 15 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 1260 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1982 | 13 | 0.010 |
Why?
|
| Humerus | 1 | 2001 | 86 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 2001 | 520 | 0.010 |
Why?
|
| Receptors, Interleukin-11 | 1 | 1997 | 1 | 0.010 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 1997 | 1 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 1997 | 3 | 0.010 |
Why?
|
| Esterases | 1 | 1993 | 1 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 1993 | 2 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1993 | 5 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1993 | 5 | 0.010 |
Why?
|
| Heparitin Sulfate | 1 | 1993 | 3 | 0.010 |
Why?
|
| Trypsin | 1 | 1993 | 4 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1993 | 35 | 0.010 |
Why?
|
| Fluorescence Polarization | 1 | 1991 | 1 | 0.010 |
Why?
|
| Phospholipids | 1 | 1991 | 9 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1991 | 33 | 0.010 |
Why?
|
| Humans | 2 | 1997 | 23144 | 0.010 |
Why?
|
| Cell Count | 1 | 1989 | 70 | 0.000 |
Why?
|